AbbVie ROI - Return on Investment 2010-2024 | ABBV

AbbVie return on investment for the quarter ending June 30, 2024 was 8.

  • AbbVie average return on investment for 2023 was 9.55, a 39.52% decline from 2022.
  • AbbVie average return on investment for 2022 was 15.79, a 80.87% decline from 2021.
  • AbbVie average return on investment for 2021 was 8.73, a 27.79% increase from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

AbbVie ROI - Return on Investment 2010-2024 | ABBV

  • AbbVie average return on investment for 2023 was 9.55, a 39.52% decline from 2022.
  • AbbVie average return on investment for 2022 was 15.79, a 80.87% decline from 2021.
  • AbbVie average return on investment for 2021 was 8.73, a 27.79% increase from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.